Table 2.
Antimicrobial (mg/ml) | Strain | |||||
---|---|---|---|---|---|---|
ATCC 10832 | Newman | USA 300 | ATCC 29213 | ATCC 33591 | S.a. 3255 | |
Individual components | ||||||
Garvicin KS | 2.5 | 1.25 | 2.5 | 1.25 | >5 | 1.25 |
Micrococcin P1 | >1.0 × 10−1 | >1.0 × 10−1 | >1.0 × 10−1 | >1.0 × 10−1 | >1.0 × 10−1 | >1.0 × 10−1 |
Combination | ||||||
Garvicin KS | 1.25 | 1.25 | 5 | 1.25 | >5 | 3.1×10−1 |
Micrococcin P1 | 2.5 × 10−2 | 2.5 × 10−2 | 1.0 × 10−1 | 2.5 × 10−2 | >1.0 × 10−1 | 2.5 × 10−2 |
FICa | 0.75 | 1.25 | 1.5 | 1.25 | NDb | 0.5 |
aSynergy achieved with fractional inhibition concentration (FIC) ≤ 0.5.
bNot determined. The MIC values exceeded the maximum concentration tested: micrococcin P1, 1.0 × 10−1 mg/ml; garvicin KS, 5 mg/ml.